Skip to main content

July 2015 - FRMC

07/30/2015
Eileen Koutnik-Fotopoulos
The UNCOVER-2 study found that ixekizumab (anti-interleuekin-17A IgG4 monoclonal antibody) was superior to placebo and etanercept in psoriasis patients.
The UNCOVER-2 study found that ixekizumab (anti-interleuekin-17A IgG4 monoclonal antibody) was superior to placebo and etanercept in psoriasis patients.
The UNCOVER-2 study found that...
07/30/2015
First Report Managed Care
News
07/30/2015
Eileen Koutnik-Fotopoulos
Vancouver, Canada—Severity of psoriasis has a significant impact on patient quality of life. In a new study, researchers conducted a cross-sectional survey among patients with psoriasis and included questions to assess the avoidance of...
Vancouver, Canada—Severity of psoriasis has a significant impact on patient quality of life. In a new study, researchers conducted a cross-sectional survey among patients with psoriasis and included questions to assess the avoidance of...
Vancouver, Canada—Severity of...
07/30/2015
First Report Managed Care
07/30/2015
Mary Beth Nierengarten
Chemoprevention is used to target populations with preneoplastic lesions such as ductal in situ carcinoma and familial adenomatous polyposis.
Chemoprevention is used to target populations with preneoplastic lesions such as ductal in situ carcinoma and familial adenomatous polyposis.
Chemoprevention is used to...
07/30/2015
First Report Managed Care
07/30/2015
Eileen Koutnik-Fotopoulos
In a new study, researchers sought to evaluate the cost per additional responder associated with 4 biologics to achieve PASI 75, PASI 90, and PASI 100.
In a new study, researchers sought to evaluate the cost per additional responder associated with 4 biologics to achieve PASI 75, PASI 90, and PASI 100.
In a new study, researchers...
07/30/2015
First Report Managed Care
07/30/2015
Eileen Koutnik-Fotopoulos
Philadelphia, PA—A brief pharmacist telephone intervention resulted in significantly better proportion of days covered (PDCs) during the 6 months following the intervention among a group of nonadherent patients with comorbid hypertension and...
Philadelphia, PA—A brief pharmacist telephone intervention resulted in significantly better proportion of days covered (PDCs) during the 6 months following the intervention among a group of nonadherent patients with comorbid hypertension and...
Philadelphia, PA—A brief...
07/30/2015
First Report Managed Care
07/30/2015
With advances in cancer treatment, patients face increasingly more complex treatment and follow-up decisions that require efficient coordination within the health care system to optimize outcomes. 
With advances in cancer treatment, patients face increasingly more complex treatment and follow-up decisions that require efficient coordination within the health care system to optimize outcomes. 
With advances in cancer...
07/30/2015
First Report Managed Care
Conference Insider
07/30/2015
Eileen Koutnik-Fotopoulos
Orlando, FL—Antiplatelet and anticoagulant therapies are crucial in the management of patients with acute coronary syndrome (ACS). Platelet activation remains a major pathophysiological issue in ACS. Platelets upregulate the expression of...
Orlando, FL—Antiplatelet and anticoagulant therapies are crucial in the management of patients with acute coronary syndrome (ACS). Platelet activation remains a major pathophysiological issue in ACS. Platelets upregulate the expression of...
Orlando, FL—Antiplatelet...
07/30/2015
First Report Managed Care
Conference Insider
07/30/2015
Mary Beth Nierengarten
Orlando, FL—Changes in the health care delivery system are placing demands on hospitals and physicians to become more competitive in a marketplace that is moving from fee-for-service payment models and pay-for-performance models to...
Orlando, FL—Changes in the health care delivery system are placing demands on hospitals and physicians to become more competitive in a marketplace that is moving from fee-for-service payment models and pay-for-performance models to...
Orlando, FL—Changes in the...
07/30/2015
First Report Managed Care
Conference Insider
07/30/2015
Inflammatory bowel disease (IBD) affects more than 1 million people in the United States. IBD encompasses a variety of clinical signs and symptoms including abdominal pain, diarrhea, and rectal bleeding.
Inflammatory bowel disease (IBD) affects more than 1 million people in the United States. IBD encompasses a variety of clinical signs and symptoms including abdominal pain, diarrhea, and rectal bleeding.
Inflammatory bowel disease (IBD)...
07/30/2015
First Report Managed Care
07/30/2015
Mary Beth Nierengarten
“Although the exchange market is still small, it is important for the managed care industry to be on the forefront of trends in formulary management,” said Caroline Pearson, vice president, health reform and policy, Avalere Health,...
“Although the exchange market is still small, it is important for the managed care industry to be on the forefront of trends in formulary management,” said Caroline Pearson, vice president, health reform and policy, Avalere Health,...
“Although the exchange market is...
07/30/2015
First Report Managed Care
07/30/2015
Mary Beth Nierengarten
“Pharmacists can affect medication utilization and expenditures within an accountable care organization [ACO],” said Dan Dauner, PharmD, MSPH, BCPS-AQ ID, pharmacy manager, Population Care Management Department, Essentia Health, during a...
“Pharmacists can affect medication utilization and expenditures within an accountable care organization [ACO],” said Dan Dauner, PharmD, MSPH, BCPS-AQ ID, pharmacy manager, Population Care Management Department, Essentia Health, during a...
“Pharmacists can affect...
07/30/2015
First Report Managed Care
07/30/2015
Eileen Koutnik-Fotopoulos
As specialty pharmacy spend continues to skyrocket, payers will need to implement innovative strategies that minimize cost, increase plan value, and improve overall member health outcomes. These strategies must also address comorbidities,...
As specialty pharmacy spend continues to skyrocket, payers will need to implement innovative strategies that minimize cost, increase plan value, and improve overall member health outcomes. These strategies must also address comorbidities,...
As specialty pharmacy spend...
07/30/2015
First Report Managed Care
07/30/2015
Kathleen P. Wolff, MBA
Forging a pathway of innovation is typically either with allies, but in the world of biosimilars, where stakeholders are still sizing each other up, allies are scarce. 
Forging a pathway of innovation is typically either with allies, but in the world of biosimilars, where stakeholders are still sizing each other up, allies are scarce. 
Forging a pathway of innovation...
07/30/2015
First Report Managed Care
News
07/30/2015
Melissa D. Cooper
The estimated overall survival rate of patients diagnosed with Stage I Hodgkin lymphoma is 90%, while Stage IV has a 65% survival rate.
The estimated overall survival rate of patients diagnosed with Stage I Hodgkin lymphoma is 90%, while Stage IV has a 65% survival rate.
The estimated overall survival...
07/30/2015
First Report Managed Care
News
07/30/2015
Melissa D. Cooper
Approximately 28.8% of pregnancies are unintended under employer-sponsored insurance plans, and they account for 27.4% of annual delivery costs to employers.
Approximately 28.8% of pregnancies are unintended under employer-sponsored insurance plans, and they account for 27.4% of annual delivery costs to employers.
Approximately 28.8% of...
07/30/2015
First Report Managed Care
Conference Insider
07/30/2015
Jill Sederstorm
Several studies have found that prescribing testosterone to men with low levels of the hormone could increase therisk of cardiovascular events.    
Several studies have found that prescribing testosterone to men with low levels of the hormone could increase therisk of cardiovascular events.    
Several studies have found that...
07/30/2015
First Report Managed Care
Conference Insider
07/30/2015
Mary Mihalovic
Retrospective claims analysis points to the likely reasons, and compares cost burden to that of ulcerative colitis.
Retrospective claims analysis points to the likely reasons, and compares cost burden to that of ulcerative colitis.
Retrospective claims analysis...
07/30/2015
First Report Managed Care
07/30/2015
Mary Mihalovic
Researchers adapted a validated decision analytic model of CRC screening to explore potential effectiveness and cost-effectiveness.
Researchers adapted a validated decision analytic model of CRC screening to explore potential effectiveness and cost-effectiveness.
Researchers adapted a validated...
07/30/2015
First Report Managed Care